Indications and uses
For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness
For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness
• to prevent motion sickness, take the first dose 1/2 to 1 hour before starting activity • not for frequent or prolonged use except on the advice of a doctor • do not exceed recommended dose Adults and children 12 years of age and older Take 1-2 tablets once daily, or as directed by a doctor. Do not exceed 2 tablets in 24 hours.
• TAMPER EVIDENT: Do not use if imprinted seal under cap is broken or missing. • store at room temperature 15˚-30˚C (59˚-86˚F) • protect from heat and humidity
Meclizine HCI 25mg
Antiemetic
For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness
Do not use in children under 12 years of age unless directed by a doctor.
Ask a doctor before use if you have
• breathing problems, such as emphysema or chronic bronchitis
• glaucoma
• difficulty urinating due to an enlarged prostate gland
A sk a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
When using this product
• drowsiness may occur
• avoid alcoholic beverages
• alcohol, sedatives and tranquilizers may increase drowsiness
• use caution when driving a motor vehicle or operating machinery
I
f
pregnant or breast-feeding,ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
• to prevent motion sickness, take the first dose 1/2 to 1 hour before starting activity
• not for frequent or prolonged use except on the advice of a doctor
• do not exceed recommended dose
| Adults and children 12
years of age and older | Take 1-2 tablets once daily, or as directed by a doctor.
Do not exceed 2 tablets in 24 hours. |
• TAMPER EVIDENT:Do not use if imprinted seal under cap is broken or missing.
• store at room temperature 15˚-30˚C (59˚-86˚F)
• protect from heat and humidity
D&C yellow # 10 lake, lactose, magnesium stearate, microcrystalline cellulose, silica
1-800-540-3765
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68016-716 | 68016-716-20 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| D&C YELLOW NO. 10 | 35SW5USQ3G | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ee12d0e8-b516-ce0f-e053-2995a90a3471 | bdaad727-068d-2f2f-e053-2995a90a0de9 | 2022-11-22 | Warnings | ee12d0e8-b516-ce0f-e053-2995a90a3471 bdaad727-068d-2f2f-e053-2995a90a0de9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.